Skip to Content

Nesiritide Pregnancy and Breastfeeding Warnings

Nesiritide is also known as: Natrecor

Medically reviewed on April 2, 2018

Nesiritide Pregnancy Warnings

Animal reproductive studies have failed to reveal evidence of adverse effects on live births or fetal development. There are no controlled data in human pregnancy.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

US FDA pregnancy category: C

See references

Nesiritide Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments: The effects in nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Natrecore (nesiritide)" Scios Inc, Sunnyvale, CA.

References for breastfeeding information

  1. "Product Information. Natrecore (nesiritide)" Scios Inc, Sunnyvale, CA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide